NCT04737083 is a clinical trial of CGH array in Clubfoot, sponsored by Central Hospital, Nancy, France.

Who is sponsoring NCT04737083?

NCT04737083 is sponsored by Central Hospital, Nancy, France.

What drugs are being tested in NCT04737083?

Interventions in NCT04737083: CGH array.

What condition does NCT04737083 study?

NCT04737083 studies Clubfoot, Prenatal Disorder.

Is NCT04737083 still recruiting?

NCT04737083 is currently status unknown. Last updated 3 February 2021.

Last reviewed 2021-02-03 · How we verify

NCT04737083

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CGH Array in Bilateral Clubfoot

Status unknown Last updated 3 February 2021

What this trial tests

trial testing CGH array in Clubfoot in 50 participants. Status unknown.

Timeline

31 January 2021

Primary endpoint
15 February 2021

30 November 2021

Quick facts

Lead sponsor	Central Hospital, Nancy, France
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	31 January 2021
Primary completion	15 February 2021
Estimated completion	30 November 2021

Drugs / interventions tested

CGH array

Conditions studied

Clubfoot — all drugs for Clubfoot →
Prenatal Disorder — all drugs for Prenatal Disorder →

Sponsor

Central Hospital, Nancy, France

Who can join

18 and older, female only, with Clubfoot or Prenatal Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In prenatal diagnosis of isolated bilateral clubfoot our team propose genetic analysis: a CGH-array. We want to study the rate of aberrations in these cases.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Clubfoot

Currently open trials in the same condition.

NCT06906406 — Health-Related Quality of Life in Children and Adolescents With Clubfoot · recruiting
NCT06050746 — Predictive Value of the PBS-score in Children With Clubfoot · active not recruiting
NCT04766684 — Comparison Study of LMX4 Cream Versus J-Tip Needle-Free Injection System With Lidocaine for In-Office PAT for Clubfoot · Phase 4 · active not recruiting

Other Central Hospital, Nancy, France trials

Trials by the same sponsor.

NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04737083 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
Last refreshed: 3 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04737083.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing